What is the prevalence of Aicardi Syndrome?

Aicardi Syndrome is an ultra-rare neurodevelopmental disorder with an estimated prevalence between 1 in 100,000 and 1 in 250,000 live births globally. Because the condition occurs almost exclusively in females and often presents with complex symptoms, true incidence rates are difficult to determine due to potential underdiagnosis or misdiagnosis in milder cases.

Is Aicardi Syndrome considered a rare disease?

Yes, Aicardi Syndrome is classified as an ultra-rare condition. While exact global numbers are elusive, the NIH Genetic and Rare Diseases Information Center (GARD) notes that fewer than 1,000 cases have been reported in medical literature worldwide. Our own DiseaseMaps.org community reflects this rarity, with 13 individuals currently connected through our platform to share their experiences with Aicardi Syndrome.

How does gender and age impact the prevalence of Aicardi Syndrome?

Aicardi Syndrome almost exclusively affects females, which is a hallmark of the condition. It is hypothesized to be an X-linked dominant disorder that is typically lethal in males. Regarding age of onset, it is strictly a pediatric-onset condition; clinical symptoms, including characteristic infantile spasms, typically emerge within the first few months of life.

Why is it difficult to calculate the exact prevalence of Aicardi Syndrome?

Accurate epidemiological data for Aicardi Syndrome is limited by several factors:

• Diagnostic Complexity: The classic triad (corpus callosum agenesis, chorioretinal lacunae, and infantile spasms) may not be present in every patient, leading to missed diagnoses.


• Clinical Variability: Mild cases may go unrecognized if the neurological symptoms are less severe or mistaken for other epilepsy syndromes.


• Geographic Reporting: Data collection varies significantly by region, with higher identification rates in countries with robust pediatric neurological surveillance systems.

Are there geographic or ethnic variations for Aicardi Syndrome?

Current clinical research does not suggest any specific geographic or ethnic predisposition for Aicardi Syndrome. It appears to occur sporadically across all populations, with no evidence of clustering in specific ethnic groups or regions.

Next steps

• Consult with a pediatric neurologist or a clinical geneticist to discuss specific diagnostic testing.


• Connect with the Aicardi Syndrome community at DiseaseMaps.org to share insights with the 13 members currently active on our platform.


• Visit the Aicardi Syndrome Foundation for resources on ongoing research and family support.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Aicardi Syndrome overview.


• Orphanet: Prevalence and epidemiology of rare neurological disorders.


• OMIM (Online Mendelian Inheritance in Man): Aicardi Syndrome (Entry #304050).


• Aicardi Syndrome Foundation: Clinical research and patient registry data.